Effect of opioids on oral Salmonella infection and immune function.
Eisenstein
L K
LK
Center for Substance Abuse Research, Department of Microbiology and Immunology, Temple University School of Medicine Philadelphia, PA 19140, USA.
MacFarland
A S
AS
Peng
X
X
Hilburger
M E
ME
Rahim
R T
RT
Meissler
L J
LJ
Rogers
T J
TJ
Wan
A C
AC
Adler
M W
MW
D019900:3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer / Q000008:administration & dosage / Q000633:toxicity; D000818:Animals; D004343:Drug Implants; D005260:Female; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000633:toxicity; D015918:Infusion Pumps, Implantable; D051379:Mice; D008809:Mice, Inbred C3H; D009020:Morphine / Q000008:administration & dosage / Q000633:toxicity; D009059:Mouth Diseases / Q000276:immunology*; D009271:Naltrexone / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology; D009294:Narcotics / Q000008:administration & dosage / Q000633:toxicity*; D009842:Oligopeptides / Q000008:administration & dosage / Q000633:toxicity; D017465:Receptors, Opioid, delta / Q000819:agonists; D017473:Receptors, Opioid, kappa / Q000819:agonists; D017450:Receptors, Opioid, mu / Q000819:agonists; D012481:Salmonella Infections, Animal / Q000276:immunology*; D012486:Salmonella typhimurium
D004343:Drug Implants; D007166:Immunosuppressive Agents; D009292:Narcotic Antagonists; D009294:Narcotics; D009842:Oligopeptides; D017465:Receptors, Opioid, delta; D017473:Receptors, Opioid, kappa; D017450:Receptors, Opioid, mu; C060209:deltorphin II, Ala(2)-; D009271:Naltrexone; D019900:3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; D009020:Morphine